Hikma announces global agreement with Vectura to develop generic versions of GSK’s Ellipta portfolio
Hikma Pharmaceuticals PLC announces that it has signed an agreement with Vectura Group plc (Vectura) for the global development and commercialisation of generic versions of…
Read More...
Read More...
